These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34418431)

  • 1. Bystander CD4 T-cell death is inhibited by broadly neutralizing anti-HIV antibodies only at levels blocking cell-to-cell viral transmission.
    Luo X; Mouquet H; Schwartz O; Greene WC
    J Biol Chem; 2021 Oct; 297(4):101098. PubMed ID: 34418431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
    Li H; Zony C; Chen P; Chen BK
    J Virol; 2017 May; 91(9):. PubMed ID: 28148796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 cell-to-cell transmission and broadly neutralizing antibodies.
    Dufloo J; Bruel T; Schwartz O
    Retrovirology; 2018 Jul; 15(1):51. PubMed ID: 30055632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission.
    Malbec M; Porrot F; Rua R; Horwitz J; Klein F; Halper-Stromberg A; Scheid JF; Eden C; Mouquet H; Nussenzweig MC; Schwartz O
    J Exp Med; 2013 Dec; 210(13):2813-21. PubMed ID: 24277152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
    McGuire AT; Glenn JA; Lippy A; Stamatatos L
    J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent.
    Reh L; Magnus C; Schanz M; Weber J; Uhr T; Rusert P; Trkola A
    PLoS Pathog; 2015 Jul; 11(7):e1004966. PubMed ID: 26158270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
    Dupuy FP; Kant S; Barbé A; Routy JP; Bruneau J; Lebouché B; Tremblay C; Pazgier M; Finzi A; Bernard NF
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Matter of Life or Death: Productively Infected and Bystander CD4 T Cells in Early HIV Infection.
    Cao D; Khanal S; Wang L; Li Z; Zhao J; Nguyen LN; Nguyen LNT; Dang X; Schank M; Thakuri BKC; Zhang J; Lu Z; Wu XY; Morrison ZD; El Gazzar M; Ning S; Moorman JP; Yao ZQ
    Front Immunol; 2020; 11():626431. PubMed ID: 33643305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies.
    Ducloy C; Su B; Mayr L; Klingler J; Decoville T; Schmidt S; Laumond G; Salomé N; Bahram S; Moog C
    AIDS; 2018 Jun; 32(10):1239-1245. PubMed ID: 29683853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV.
    Zhang Y; Chapman JH; Ulcay A; Sutton RE
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.
    Mujib S; Liu J; Rahman AKMN; Schwartz JA; Bonner P; Yue FY; Ostrowski MA
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection.
    Sagar M; Akiyama H; Etemad B; Ramirez N; Freitas I; Gummuluru S
    J Infect Dis; 2012 Apr; 205(8):1248-57. PubMed ID: 22396600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-2 Depletes CD4 T Cells through Pyroptosis despite Vpx-Dependent Degradation of SAMHD1.
    Luo X; Herzig E; Doitsh G; Grimmett ZW; Muñoz-Arias I; Greene WC
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
    Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
    Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE
    J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broadly neutralizing antibodies potently inhibit cell-to-cell transmission of semen leukocyte-derived SHIV162P3.
    Suphaphiphat K; Tolazzi M; Hua S; Desjardins D; Lorin V; Dereuddre-Bosquet N; Mouquet H; Scarlatti G; Grand RL; Cavarelli M
    EBioMedicine; 2020 Jul; 57():102842. PubMed ID: 32619962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early preservation of CXCR5+ PD-1+ helper T cells and B cell activation predict the breadth of neutralizing antibody responses in chronic HIV-1 infection.
    Cohen K; Altfeld M; Alter G; Stamatatos L
    J Virol; 2014 Nov; 88(22):13310-21. PubMed ID: 25210168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralisation of HIV-1 cell-cell spread by human and llama antibodies.
    McCoy LE; Groppelli E; Blanchetot C; de Haard H; Verrips T; Rutten L; Weiss RA; Jolly C
    Retrovirology; 2014 Oct; 11():83. PubMed ID: 25700025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.